TipRanks
Advertisement
Advertisement
Organigram Earns Buy Rating as Sanity Acquisition Drives Record EBITDA and Reaffirms Strong FY Outlook
PremiumRatingsOrganigram Earns Buy Rating as Sanity Acquisition Drives Record EBITDA and Reaffirms Strong FY Outlook
2M ago
Organigram Posts Record Q3 2026 Results on Sanity Group-Driven Global Expansion
Premium
Company Announcements
Organigram Posts Record Q3 2026 Results on Sanity Group-Driven Global Expansion
2M ago
Organigram reports Q3 net revenue $105.78M vs. $70.79M last year
Premium
The Fly
Organigram reports Q3 net revenue $105.78M vs. $70.79M last year
2M ago
Organigram Global Files Q2 2026 Results as Sanity Group Deal Extends European Cannabis Reach
PremiumCompany AnnouncementsOrganigram Global Files Q2 2026 Results as Sanity Group Deal Extends European Cannabis Reach
5M ago
Organigram reports Q2 net revenue $59.8M, consensus $68.83M
Premium
The Fly
Organigram reports Q2 net revenue $59.8M, consensus $68.83M
5M ago
Organigram sees FY26 revenue over $350M, consensus $341.45M
Premium
The Fly
Organigram sees FY26 revenue over $350M, consensus $341.45M
5M ago
Organigram Shareholders Back Sanity Group Deal, Deepening European Cannabis Push
PremiumCompany AnnouncementsOrganigram Shareholders Back Sanity Group Deal, Deepening European Cannabis Push
6M ago
Organigram Wins Shareholder Backing for Sanity Group Deal and Board Slate
Premium
Company Announcements
Organigram Wins Shareholder Backing for Sanity Group Deal and Board Slate
6M ago
ISS Backs Organigram’s Premium-Priced Acquisition of Sanity Group
Premium
Company Announcements
ISS Backs Organigram’s Premium-Priced Acquisition of Sanity Group
7M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―